CYCC - Cyclacel Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 518.93M
Enterprise Value 3-6.98M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)68.33
Price/Book (mrq)0.79
Enterprise Value/Revenue 3-25.18
Enterprise Value/EBITDA 60.67

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,776.90%

Management Effectiveness

Return on Assets (ttm)-25.89%
Return on Equity (ttm)-41.77%

Income Statement

Revenue (ttm)277k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)843k
EBITDA -10.41M
Net Income Avi to Common (ttm)-15.65M
Diluted EPS (ttm)-2.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.02M
Total Cash Per Share (mrq)2.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.52
Book Value Per Share (mrq)2.01

Cash Flow Statement

Operating Cash Flow (ttm)-8.2M
Levered Free Cash Flow (ttm)-4.81M

Trading Information

Stock Price History

Beta 4.23
52-Week Change 3-70.26%
S&P500 52-Week Change 315.51%
52 Week High 310.90
52 Week Low 31.47
50-Day Moving Average 31.68
200-Day Moving Average 31.76

Share Statistics

Avg Vol (3 month) 3586.13k
Avg Vol (10 day) 382.52k
Shares Outstanding 511.9M
Float 9.59M
% Held by Insiders 119.32%
% Held by Institutions 16.39%
Shares Short 3790.56k
Short Ratio 32.24
Short % of Float 325.50%
Shares Short (prior month) 3747.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Aug 1, 2016
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3May 31, 2016